MARKET

NCNA

NCNA

Nucana
NASDAQ
0.0482
+0.0044
+10.05%
Pre Market: 0.0485 +0.0003 +0.62% 09:11 05/20 EDT
OPEN
0.0507
PREV CLOSE
0.0438
HIGH
0.0510
LOW
0.0467
VOLUME
7.47M
TURNOVER
0
52 WEEK HIGH
10.79
52 WEEK LOW
0.0325
MARKET CAP
411.14K
P/E (TTM)
-0.0060
1D
5D
1M
3M
1Y
5Y
1D
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
Weekly Report: what happened at NCNA last week (0512-0516)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 5d ago
Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
Weekly Report: what happened at NCNA last week (0505-0509)?
Weekly Report · 05/12 09:04
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 05/09 17:06
More
About NCNA
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-3373, and NUC-7738. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). 5-FU is a prescribed anti-cancer agent. NUC-3373 has been evaluated in a Phase I clinical trial for patients with advanced solid tumors and is under Phase Ib/II clinical trial for patients with advanced colorectal cancer. NUC-7738 is a ProTide transformation of a nucleoside analog, 3’-deoxyadenosine (3’-Da). The Company is evaluating NUC-7738 in a Phase I/II clinical trial for patients with advanced solid tumors. Its pipeline also includes Acelari, which is a ProTide transformation of the nucleoside analog gemcitabine. The Company’s subsidiaries include NuCana, Inc., NuCana Limited and NuCana BioMed Trustee Company Limited.

Webull offers NuCana PLC (ADR) stock information, including NASDAQ: NCNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NCNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NCNA stock methods without spending real money on the virtual paper trading platform.